AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PEFLOXACIN

9 registrations across 2 African markets— 9 active

Markets with PEFLOXACIN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Peflovin Caplet 400 mg_
Capsule
🇳🇬NigeriaAvro Pharma LimitedactiveNov 2030
Pefloxacin 400 mg Tablets_
Tablet
🇳🇬NigeriaFreshborn Industries LtdactiveOct 2030
Peflotab
Tablet
🇳🇬NigeriaFidson Healthcare PLCactiveOct 2026
Floxal Tablet
Tablet
🇳🇬NigeriaAquatix Pharmaceuticals LimitedactiveJun 2026
Nelb Pefloxacin 400 mg Tablets
Tablet
🇳🇬NigeriaChrisnelb Pharma LtdactiveDec 2025
PEFLOXACIN
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaGITTOES PHARMACEUTICA LS LIMITEDactive
PEFLOXACIN
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaGITTOES PHARMACEUTICA LS LIMITEDactive
PEFLOXACIN
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaGITTOES PHARMACEUTICA LS LIMITEDactive
PEFLOXACIN
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaGITTOES PHARMACEUTICA LS LIMITEDactive

PEFLOXACIN in Africa — Regulatory Overview

PEFLOXACIN is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Uganda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.